Login / Signup

Intravenous immunoglobulin (IVIg) provides protection against endothelial cell dysfunction and death in ischemic stroke.

Alexander WidiapradjaTomislav SantroMilan BastaChristopher G SobeySilvia ManzaneroThiruma V Arumugam
Published in: Experimental & translational stroke medicine (2014)
IVIg protects endothelial cells from ischemic insult. These studies support the use of IVIg as a pharmacological intervention for stroke therapy.
Keyphrases
  • endothelial cells
  • atrial fibrillation
  • randomized controlled trial
  • oxidative stress
  • high dose
  • cerebral ischemia
  • high glucose
  • stem cells
  • low dose
  • blood brain barrier
  • smoking cessation